These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6758353)

  • 21. [Correction of hemodynamic and metabolic disorders in patients with ischemic heart disease].
    Bondarenko IP
    Vrach Delo; 1988 Mar; (3):31-4. PubMed ID: 3394292
    [No Abstract]   [Full Text] [Related]  

  • 22. [Digoxin in chronic heart failure].
    Motz W
    Dtsch Med Wochenschr; 1993 Dec; 118(48):1786. PubMed ID: 8253039
    [No Abstract]   [Full Text] [Related]  

  • 23. [Contribution to the treatment of chronic renal insufficiency with anabolic drugs].
    Andronescu M; Andronescu L
    Med Interna (Bucur); 1965 Nov; 17(11):1309-14. PubMed ID: 5864343
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of coronary heart disease using Cormelian-Digotab: influence of the duration of therapy. 2. Field study by 107 physicians].
    Pollter J; Schnitker J
    Med Welt; 1976 Oct; 27(43):2074-9. PubMed ID: 792623
    [No Abstract]   [Full Text] [Related]  

  • 25. Medical management of heart failure secondary to coronary artery disease.
    Challapalli S; Bonow RO; Gheorghiade M
    Coron Artery Dis; 1998; 9(10):659-74. PubMed ID: 9894618
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical assessment of the use of strophanthin and Nerobol in cardiac insufficiency].
    Polishchuk MA
    Klin Med (Mosk); 1970 Feb; 48(2):53-6. PubMed ID: 5425983
    [No Abstract]   [Full Text] [Related]  

  • 27. Soluble tumour necrosis factor alpha receptor 2, a serum marker of resistance to the anabolic actions of growth hormone in subjects with HIV disease.
    Gelato MC; Mynarcik D; McNurlan MA
    Clin Sci (Lond); 2002 Jan; 102(1):85-90. PubMed ID: 11749664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of anabolic hormones and aminokrovin in children with chronic enterocolitis].
    Bodnia IA
    Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):8-11. PubMed ID: 4765478
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapy of ischemic and nonischemic heart failure. Current status and prospects].
    Weil J; Riegger G
    Internist (Berl); 2002 Apr; 43 Suppl 1():S8, S11-8. PubMed ID: 11993003
    [No Abstract]   [Full Text] [Related]  

  • 30. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure.
    von Haehling S; Doehner W; Anker SD
    Cardiovasc Res; 2007 Jan; 73(2):298-309. PubMed ID: 17034772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of anabolic steroids on the chronic circulatory insufficiency of arteriosclerotic origin].
    Dubinskiĭ AA; Zhukova SV; Bondarenko IP
    Kardiologiia; 1974 Aug; 14(8):129-31. PubMed ID: 4431153
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anabolic steroids in the overall treatment of pulmonary tuberculosis in the middle-aged and elderly].
    Iashchenko BP; Berezitskii AV; Babinskaia IR
    Probl Tuberk; 1980 Jan; (1):26-30. PubMed ID: 7367420
    [No Abstract]   [Full Text] [Related]  

  • 33. [Anabolic therapy of osteoporosis].
    Okopień B; Krysiak R; Labuzek K; Herman ZS
    Pol Merkur Lekarski; 2005 Jul; 19(109):118-21. PubMed ID: 16194044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of anabolic preparations in atherosclerotic cardiosclerosis].
    Agapova EN; Tkachenko AM; Krutovskaia OV
    Klin Med (Mosk); 1974 Jan; 52(1):42-4. PubMed ID: 4466884
    [No Abstract]   [Full Text] [Related]  

  • 35. [In heart diseases, differential hypertension therapy].
    Werner N; Böhm M
    MMW Fortschr Med; 2003 Mar; 145(11):45-8. PubMed ID: 12688196
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of steroid and nonsteroid anabolites in ischemic heart disease].
    Leshchinskiĭ LA; Shinkareva IA
    Klin Med (Mosk); 1976 Apr; 54(4):38-43. PubMed ID: 1016367
    [No Abstract]   [Full Text] [Related]  

  • 37. [The use of cytoflavin for the treatment of chronic brucellosis].
    Shul'diakov AA; Liapina EP; Soboleva LA; Reshetnikov AA; Zubareva EV; Trubetskov AD; Anashchenko AV; Evdokimov AV
    Klin Med (Mosk); 2011; 89(2):56-8. PubMed ID: 21574446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anabolic steroid nerobol in the therapy of patients with chronic coronary insufficiency].
    Leshchinskiĭ LA; Pevchikh VV; Petrov NM; Kharitonova VV
    Kardiologiia; 1970; 10(4):32-6. PubMed ID: 5497922
    [No Abstract]   [Full Text] [Related]  

  • 39. On equivalence.
    Malik P
    Can J Cardiol; 2003 Aug; 19(9):992. PubMed ID: 12915924
    [No Abstract]   [Full Text] [Related]  

  • 40. [The lessons from clinical trials in congestive heart failure].
    Anguita Sánchez M
    Rev Esp Cardiol; 1995 Nov; 48(11):699-709. PubMed ID: 8532939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.